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Abstract.  Brain microtubule-associated protein 2 
(MAP2) consists of a pair of high molecular mass 
(280 kD) polypeptides, MAP2a and MAP2b, and a re- 
cently identified 70-kD protein,  MAP2c, which is anti- 
genically related to these high molecular mass 
MAP2's.  Using cDNA clones we have analyzed the 
expression of these three proteins at the nucleic acid 
level, cDNA probes selective for the high molecular 
mass MAP2's a and b  identified only a 9-kb mRNA, 
whereas a probe for sequence common to all three 
MAP2 isoforms, a, b, and c, recognized the 9-kb tran- 
script and additionally a 6-kb mRNA.  Southern blot 
analysis with cDNA probes indicated that there is only 
one MAP2 gene from which these two distinct 
mRNAs are derived. The 70-kD MAP2c protein is 
much more abundant in neurons of developing brain 
than those of adult tissues.  Similarly the expression of 
the 6-kb MAP2c-related mRNA, is much greater in 
neonatal than adult rat brain,  indicating that the de- 
velopmental expression of MAP2 is determined by 
transcriptional  regulation from a  single MAP2 gene. 
tJRING brain maturation  striking changes occur in the 
abundance  and cellular distribution  of neuronal  mi- 
crotubule-associated proteins  (MAPs)  ~ (2,  18,  19). 
Since several of the neuronal MAPs promote microtubule as- 
sembly in vitro (6, 10) and appear to cross-link the neuronal 
cytoskeleton in vivo (7, 23) it has been suggested  that the 
MAPs play an important role in regulating neuronal morpho- 
genesis (2,  17,  19, 20). 
The most abundant of these proteins, MAP2, occurs as two 
high  molecular mass components (Mr  >  200,000),  MAPs 
2a and 2b, (5, 6) that  are highly  concentrated  in neuronal 
dendrites (2, 18). Recently we have discovered a 70-kD pro- 
tein that is immunologically  related to MAP2 and is 10-fold 
more abundant  in juvenile than adult rat brain (21). Peptide 
mapping studies have shown that this 70-kD protein is related 
to high molecular mass MAP2 and is distinct  from the tau 
proteins  that constitute  the other MAP species in this size 
range (4).  Here we present evidence that this protein,  now 
designated MAP2c (4), is encoded by its own 6 kb mRNA that 
is derived from the same gene as the 9-kb transcript  that en- 
codes high molecular mass MAP2. By occupying microtu- 
bule-binding  sites for MAP2, this  short MAP2c molecule 
may reduce the extent of cytoskeletal cross-linking  in grow- 
ing dendrites as compared to adult dendrites in which only 
the high  molecular mass,  cross-linking  form of MAP2 is 
present. 
Materials and Methods 
A random hexanucleotide-primed cDNA library, prepared from postnatal 
day 5 rat brain poly A+ RNA, was constructed in bacteriophage ~,gtll using 
1. Abbreviation  used in this paper:  MAP, microtubule-associated protein. 
the methods described in Watson and Jackson (28) and Young  and Davis 
(29). A mouse polyclonal antiserum was raised against thrice-cycled micro- 
tubules prepared from 5-d-old rat brain by the method of Karr et al. (8). 
The mice were  injected i.p.  with 0.5  ml of a  1:1  emulsion of  1 mg/ml 
microtubule proteins with Freund's complete adjuvant on day 1. The injec- 
tion was repeated using Freund's incomplete adjuvant on day  14, and the 
mice were bled 3 d  later. This antiserum gave positive staining of MAP2 
on Western blots of 5-d-old rat brain microtubules at 1:1,000 dilution. 
The antiserum was used at 1:500 dilution to screen the ~,gtll library using 
peroxidase-conjugated  second antibody (Dako-Patts,  Copenhagen,  Den- 
mark) to detect positive clones. These were plaque purified, grown at a den- 
sity of 104 pfu/10 cm plate and overlayed with nitrocellulose filters soaked 
in 10 mM isopropyl-I!l-o-thiogalactopyranoside (Boehringer, Mannheim) to 
induce and absorb the fusion proteins. The filters, bearing immobilized fu- 
sion protein, were used to absorb monospecifie antibodies from the poly- 
clonal mixture by the method of Lewis et al. (14). These monospecifie anti- 
bodies were used to stain Western blots, and the clones 19a and 38a, whose 
fusion proteins adsorbed antibodies that reacted with MAP2, were used for 
further study.  The bridging clone 14b was isolated by rescreening the same 
library with a 38a probe radioactivity labeled by oligo-labeling with random 
primers (3) and then testing the positives for crosshybridization with an 
oligo-labeled  19a probe. 
Supernatant (S1) fractions were made from brain homogenates (21), and 
their proteins separated on SDS-polyaerylamide gels (11), blotted onto a 
nitrocellulose sheet and immunoperoxidase stained (Western blotted) as de- 
scribed by Towbin et al. (24). Escherichia  coli extracts containing fusion 
proteins were obtained by eluting the proteins directly from a plate lysate. 
L-gtll clones were grown on E.  coli strain Y1090 at 104 pfu/plate contain- 
ing 10 mM isopropyl 13-o-thiogalactopyranoside in the top agar. After in- 
cubating overnight at 37~  proteins were eluted for 1 h in t  x  SDS-poty- 
aerylamide gel sample buffer (11) and boiled for 5 min before loading on 
a gel. 
Poly A+ RNA was selected with oligo-dT cellulose from RNA isolated 
from postnatal day 5 and adult rat brain using guanidinium isothiocyanate 
as  described  by  Maniatis  et al.  (15).  Northern  blots  were  prepared  by 
separating the selected RNA on 0.8% agarose-formaldehyde gels (15) and 
blotted onto Genescreen (New England Nuclear, Boston, MA) in 25 mM 
sodium phosphate buffer, pH 6.5.  The blots were hybridized with eDNA 
probes at 10 ng/ml in 50% formarnide, 0.2% polyvinyl-pyrrolidone, 0.2% 
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The Journal of Cell Biology, Volume 106, March 1988 779-783  779 Figure 1. Western blot analysis of monospecific antibodies selected using fusion-proteins from two non-overlapping MAP2 cDNA clones. 
Protein extracts from Escherichia coli strain YI090 infected with bacteriophage L-gtll, clone 19a, or clone 38a (lanes 1-3, respectively) 
were run on a 3-15  % SDS-polyacrylamide gel, along with S1 supernatants from postnatal day 5 and adult rat brain homogenates (lanes 
4 and 5, respectively) and heat stable juvenile MAPs (lane 6). A Coomassie Blue-stained gel (A) and two Western blots made using selected 
monospecific antibodies from clone 19a (B) and 38a (C) are shown. The positions of MAP2s a, b, and c and ~.-gtl113-galactosidase  fusion 
protein (f) are indicated by lettered arrows at the right of each panel. 
BSA, 0.2% Ficol1400, 50 mM Tris-HCl, pH 7.5, 1 M NaCI, 0.1% sodium 
pyrophosphate, 1% SDS,  10% dextran sulphate and 100 Ixg/ml denatured 
salmon sperm DNA at 42 ~ for 16 h, and washed with 2  ￿  SSC and 1% 
SDS at 65 ~  The cDNA probes were labeled by nick translation (15). 
For Southern blotting rat liver DNA was prepared by the method of Blin 
and Stafford (1) and 20 I~g of DNA per well was digested with restriction 
enzymes  (Boehringer,  Mannheim).  DNA  fragments were  separated on 
0.9% agarose gels and Southern blotted onto Genescreen in 25 mM sodium 
phosphate buffer, pH 6.5, and hybridized with 10 ng/ml radioactively-labeled 
probes as described for the Northern blots. The blots were washed with 
0.3 M NaCI, 60 mM Tris-HCl, pH 8.0, 2 mM ethylenediaminetetraacetic 
acid and  I%  SDS  at 60  ~  Radioactive cDNA probes were prepared by 
oligolabeling with random primers (3). 
Results 
MAP2 clones were isolated from a rat brain Lgtll cDNA li- 
brary and characterized using monospecific antibodies se- 
lected from a  polyclonal anti-MAP  serum.  Several of the 
MAP2 clones isolated fell into one of two different classes, 
as exemplified by clones 19a and 38a. Fig.  1 shows the rela- 
tionships of these two clones to the different forms of MAP2 
protein. The monospecifie antibodies used to establish these 
relationships were selected by immunoabsorption with the 
expressed fusion proteins of clone 19a (to give monospecific 
anti-19a) and clone 38a (to give monospecific anti-38a). As 
expected, anti-19a reacts strongly with the fusion protein 
from clone 19a (Fig. 1 B, lane 2). It does not react with either 
the 13-galactosidase from Lgtll (Fig. 1 B, lane 1) or with the 
fusion protein from clone 38a (Fig. 1 B, lane 3). Conversely, 
anti-38a reacts only with the fusion protein from clone 38a 
(Fig. 1 C, lane 3) and not with any of the proteins from ~.gtll 
or clone 19a (Fig.  1 C,  lanes 1 and 2). 
The two antibodies differed in their reaction with the vari- 
ous MAP2 forms. On western blots of microtubule proteins, 
anti-19a reacted only with MAP2 a and b  (Fig.  1 B, lanes 
4-6), whereas anti-38a reacted not only with these same two 
high molecular mass proteins, but also with MAP2c (Fig. I 
C, lanes 4-6). Thus clone 19a represents sequences present 
only in MAP2a and MAP2b, whereas clone 38a corresponds 
to sequences present in all three forms. 
The cDNA 38a and 19a clones do not cross-hybridize (data 
not shown) and thus represent non-overlapping sequences. 
However, a further MAP2 cDNA clone, 14b, was identified 
that hybridized to both 38a and 19a. The existence of such 
a bridging clone indicates that the sequences in clones 38a 
and 19a represent separate domains on one continuous stretch 
of DNA.  Fig.  2  is a restriction map of these three clones 
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Figure 2.  Restriction maps of clones 38a,  14b, and  19a, showing 
their relative placement with 5' to the left and 3' to the fight, to- 
gether with restriction sites and the extent of overlaps. The probes 
38a' and  19a' used  for Southern  blot experiments  are indicated 
above. The restriction enzymes used were: E, Eco RI; S, Sal I; P, 
last I; K, Kpn I; H, Hind III. 
showing the extent of their overlap and their order, with 38a 
lying 5' to 14b, which is in turn 5' to 19a. Also shown in Fig. 
2 are the two probes, 38a' and 19a', that were used in South- 
ern blot experiments. 
Fig. 3 shows Northern blot analysis of postnatal day 5 and 
adult rat brain poly-A+  RNA with radioactive probes de- 
rived from clones 19a and 38a. The 19a probe (lanes 1 and 
2) revealed a single 9 kb mRNA that is expressed with equal 
abundance in both juvenile and adult brain. The 38a probe 
hybridized not only with the 9 kb mRNA but also with a 6  kb 
mRNA that is much more abundant in juvenile brain than 
adult (Fig.  3,  lanes 3  and 4).  The right hand panel of Fig. 
3  shows that the probes 38a' and  19a', which were used in 
Southern blot experiments (see below), hybridize with the 
same mRNAs as their respective full length cDNAs. 
To  investigate further  the  relationship  between  MAP2c 
and the 6 kb mRNA, we examined poly-A+ RNA from rat 
glioma C6  cells,  which  contain  abundant  MAP2c  but  in 
which MAP2a or MAP2b are not detectable (Fig. 4 A). If 
MAP2c is encoded on the 6 kb mRNA then these cells should 
contain the 6 kb mRNA but not the 9  kb mRNA. Fig. 4 B 
shows Northern blots ofpoly-A+ RNA from C6 cells, devel- 
oped with probes 19a and 38a. Juvenile rat brain poly-A+ 
RNA served as a positive control.  Probing with clone 19a, 
which acts as a  specific marker for the 9  kb mRNA, con- 
finned its presence in juvenile rat brain (Fig. 4  B, lane 1 ). 
Figure 3.  Developmental expression of MAP2 mRNAs. Poly A+ 
RNA (6 gg/well) from postnatal day 5 (lanes 1 and 3) and adult 
(lanes 2 and 4) rat brain were run on an 0.8 % formaldehyde agarose 
gel and hybridized with the Eco RI inserts from clone  19a (lanes 
1 and 2) and clone 38a (lanes 3 and 4). (Right) Northern blots of 
5-d-old rat brain poly A+ RNA hybridized with the probes  19a' 
and 38a' which were used in Southern blot experiments showing 
that these probes hybridize  with the  same mRNAs as the corre- 
sponding full-length clones. 
Figure 4. The 70 kD MAP2c protein is encoded by a 6 kb mRNA. 
A, Western blots of SI supernatants proteins from postnatal day 5 
rat brain (lane 1) and glioma cell line C6 (lane 2) probed with a 
monoclonal  antibody  against MAP2.  Note that glioma C6 cells 
contain only the 70 kD MAP2c protein. B, Poly A+ RNA (3 Ixg/ 
well) isolated from postnatal day 5 rat brain  (lanes 1 and 3) and 
glioma cell line C6 (lanes 2 and 4) were hybridized  with  nick- 
translated radioactive probes derived  from the Eco RI inserts of 
clone  19a (lanes 1 and 2) and clone 38a (lanes 3 and 4). Glioma 
C6 cells contain only the 6 kb mRNA (lanes 2 and 4). 
By  contrast  C6  cells  showed  no  evidence of RNA  cross- 
hybridizing with the 19a probe (Fig. 4 B, lane 2), even after 
ten times longer exposure (not shown).  Probing with clone 
38a showed that both mRNAs are present in juvenile brain 
but that only the 6 kb mRNA occurs in C6 cells (Fig. 4 B, 
lanes 3 and 4). Thus the high molecular mass MAP2's a and 
b are encoded by one or more 9 kb mRNAs whereas the 70 
kD molecular mass MAP2c is encoded by a  6  kb mRNA. 
To determine whether these two mRNAs were transcribed 
from one or two genes, Southern blots of rat genomic DNA 
were prepared using probes 19a' and 38a' (Fig. 5). The 19a' 
probe hybridizes with only single bands. Similarly, despite 
the  fact that the  38a' probe cross-reacts with  two distinct 
mRNAs on Northern  blots  (Fig.  3,  right hand  panel),  on 
Southern blots it reacted with only single bands in genomic 
DNA cut with several restriction enzymes (Fig. 5). If there 
were more than one MAP2 gene then probe 38a', which con- 
tains  sequences  represented  on  both  the  6  kb  and  9  kb 
mRNAs, should have produced two or more bands. The fact 
that it did not indicates that both mRNAs are derived from 
a  single gene. 
Discussion 
These results  demonstrate that  MAP2c  is derived from a 
6 kb mRNA that is distinct from the 9  kb mRNA that en- 
codes high molecular mass MAP2.  Other explanations for 
the occurrence of MAP2c, such as derivation from high mo- 
lecular mass MAP2 by proteolysis or other posttranslational 
modifications are thus excluded. Posttranslational modifica- 
tion of the MAP2c protein itself remains possible and is in- 
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Southern blots of total rat liver DNA (20 Itg/well) digested with ei- 
ther Kpn I, Eco RI, Hind III, Pst I, or Barn HI (lanes K, E, H, P, 
and B, respectively). The blots were hybridized with radioactive 
probes derived from either the Eco RI-Pst I fragment from clone 
19a (19a') or with the Eco RI-Sal I fragment of clone 38a (38a') 
(see Fig. 2). 
deed suggested by the presence of minor anti-MAP2-reac- 
tive bands  of similar  size to MAP2c whose exact pattern 
changes during development (Tucker, R., and A. Matus, un- 
published observations). The pattern of developmental ex- 
pression  of the  6  kb  MAP2c  mRNA  mirrors  that of the 
MAP2c polypeptide, being abundant in the developing brain 
but almost absent from adult tissue.  This implies that the 
change in levels of the MAP2c protein during development 
are due, at least in part, to transcriptional regulation. 
Even though we found two mRNAs separately encoding 
the high and low molecular mass MAP2 species, Southern 
blot analysis revealed only one rat MAP2 gene. This does 
not exclude the possibility that other MAP2-related genes 
may exist to which our probes hybridize only weakly. Lewis 
et al. also found a single MAP2 gene in mouse but they only 
detected a single 9 kb mRNA encoding high molecular mass 
MAP2 (14). Our 19a rat MAP2 eDNA clone appears to be 
analogous to the mouse MAP2 eDNA clone used by Lewis 
et al.,  since both identify only a 9  kb mRNA transcribed 
from one gene. By contrast, our clone 38a covers a different 
domain of MAP2 that apparently bears a significant sequence 
homology between MAP2, a and b and MAP2c. 
There are thus two transcripts from the MAP2 gene that 
give rise to polypeptide products of very different sizes. The 
most obvious means by which these could arise is by differ- 
ent splicing of a  primary nuclear MAP2  gene transcript. 
There are many examples of genes  that generate multiple 
mRNA transcripts via alternate splicing (12) including cases 
of developmentally regulated changes in splicing, for exam- 
ple that underlying the change from It- to 8-chain expres- 
sion  during  B  lymphocyte maturation  (16).  The  expres- 
sion of "short" and "long" forms of MAP2 appears to be a 
neuron-specific example  of this  form of developmentally 
regulated gene expression. Although at present we can only 
speculate on how the splicing occurs, it is interesting to note 
that the 9 kb and 6 kb mRNAs have quite different amounts 
of untranslated RNA, ~3.5 kb for MAP2 a and b (based on 
a polypeptide Mr of 220,000,  see reference 5) and *4.5 kb 
for MAP2c (based on a Mr of 70,000).  This leaves open the 
possibility that variable splicing may occur at either or both 
of the 5'- and 3'-ends of the primary MAP2 transcript. 
Both peptide mapping (4) and the data presented here indi- 
cate that MAP2c is homologous to a stretch of high molecu- 
lar  mass  MAP2.  Both  high  molecular  mass  MAP2  and 
MAP2c co-assemble with microtubules in vitro (reference  4, 
also see Fig.  1 above) and this, together with the structural 
homology, suggests that all three forms possess a common 
tubulin-binding domain, although their precise relationship 
remains to be established.  The tubulin-binding domain of 
high molecular mass MAP2 has been shown to be contained 
in a 35-kD fragment at one end of the molecule (26), with 
the remainder of the polypeptide protruding from the wall 
of the microtubule as an extended tail (9, 27, 30). Thus in es- 
sence MAP2c appears to be a form of MAP2 that lacks ~200 
kD from the tail domain of high molecular mass  MAP2. 
The projecting arms of high molecular mass MAP2 ap- 
pear as fine filaments that are believed to cross-link micro- 
tubules to one another and the rest of the dendritic cytoskele- 
ton (7, 23), and indeed high molecular mass MAP2 has been 
shown to bind to other cytoskeletal proteins in addition to 
tubulin (13, 22). This suggests that cross-linking of the den- 
dritic cytoskeleton by high molecular mass MAP2 may stabi- 
lize mature dendritic morphology (17). If, as our results sug- 
gest, MAP2c is a form of high molecular mass MAP2 that 
lacks much of the tail domain, then it is possible that during 
early neuronal development MAP2c stimulates tubulin poly- 
merization without cross-linking the dendritic cytoskeleton. 
This would be particularly so during the initial phase of neu- 
ronal differentiation when expression of MAP2c precedes 
that of high molecular mass MAP2 (25). Such an influence 
of MAP2c could contribute to the plastic nature of growing 
dendrites compared with the rigid form of adult dendrites in 
which only the high molecular mass  forms of MAP2  are 
present. 
Received for publication 11 September 1987, and in revised form 10 Novem- 
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